| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
8,960,000 |
| Market
Cap: |
206.08(K) |
| Last
Volume: |
52,147 |
Avg
Vol: |
52,003 |
| 52
Week Range: |
$0.023 - $0.023 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Varvaro Thomas C |
|
– • – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,543 |
3,086 |
|
- |
|
| Hansen John David |
PRESIDENT AND CEO |
• • – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,687 |
78,216 |
|
- |
|
| Cohen Kenneth M |
|
– • – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,543 |
7,557 |
|
- |
|
| Hoffman Robert |
|
– • – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,543 |
4,438 |
|
- |
|
| Maffuid Paul W |
EXECUTIVE VICE PRESIDENT |
• – – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
2,079 |
12,267 |
0.01 |
- |
|
| Hanson Gregory P |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
3,119 |
16,744 |
0.01 |
- |
|
| Hansen John David |
PRESIDENT AND CEO |
• • – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
3,119 |
37,529 |
0.01 |
- |
|
| Cohen Kenneth M |
|
– • – |
2016-08-17 |
4 |
B |
$0.00 |
$0 |
D/D |
3,119 |
6,014 |
0.01 |
- |
|
| Cohen Kenneth M |
|
– • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,417 |
11,417 |
|
- |
|
| Maier Paul V |
|
– • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,417 |
16,417 |
|
- |
|
| Hoffman Robert |
|
– • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,417 |
21,417 |
|
- |
|
| Ravetch Jeffrey V. |
|
– • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,417 |
11,417 |
|
- |
|
| Maffuid Paul W |
EXECUTIVE VICE PRESIDENT |
• – – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,944) |
75,390 |
|
- |
|
| Maffuid Paul W |
EXECUTIVE VICE PRESIDENT |
• – – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
111,334 |
116,334 |
|
- |
|
| Hansen John David |
PRESIDENT AND CEO |
• • – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(113,148) |
254,634 |
|
- |
|
| Hansen John David |
PRESIDENT AND CEO |
• • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
301,084 |
367,782 |
|
- |
|
| Varvaro Thomas C |
|
– • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,417 |
11,417 |
|
- |
|
| Scholz Wolfgang W. |
VP OF ANTIBODY DISCOVERY |
• – – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,320) |
113,288 |
|
- |
|
| Scholz Wolfgang W. |
VP OF ANTIBODY DISCOVERY |
• – – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
101,584 |
151,608 |
|
- |
|
| Hanson Gregory P |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2016-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,044) |
100,823 |
|
- |
|
| Hanson Gregory P |
CHIEF FINANCIAL OFFICER, SECR |
• – – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
155,867 |
158,867 |
|
- |
|
| Ravetch Jeffrey V. |
|
– • – |
2016-03-24 |
4 |
S |
$0.60 |
$78,900 |
D/D |
(131,500) |
0 |
|
- |
|
| Maier Paul V |
|
– • – |
2015-05-29 |
4 |
B |
$2.30 |
$11,500 |
D/D |
5,000 |
5,000 |
0.01 |
- |
|
| Cohen Kenneth M |
|
– • – |
2015-05-22 |
4 |
B |
$2.30 |
$8,050 |
I/I |
3,500 |
10,000 |
0.01 |
- |
|
| Wick Michael M |
Director |
– • – |
2015-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
33,551 |
|
- |
|
115 Records found
|
|
Page 4 of 5 |
|
|
